Qualidade do sono em pacientes insulinodependentes

Abstract

Introduction: Diabetes Mellitus is a chronic disease that may be of acquired cause or congenital, which is characterized by an inability or deficiency of the body to produce insulin in sufficient quantities. Sleep disorders with type 2 diabetes constitutes risk factors that can aggravate the pathology. This happens through the insulin resistance witch interferes with the metabolic control. During sleep, in health individuals, there is a balance between insulin secretion and glucose, however in diabetics, the balance is compromised by the occurrence of hypoglycemia. Objective: To assess the impact of sleep loss on therisk of worsening diabetesin insulin-dependent patientsand to addresstherelationship between sleep quality as an influencing factor in glucose control. Materials and Methods: This study is a cross-sectional observational study and was carried out from September 2016 to June 2018. The population of this study is made up of 200 individuals and the sample was collected at Guarda Hospital and Trancoso Health Care, whose average ages is 64,80 ± 13,670 years. Results: 31% of the individuals use medication to sleep better. The mean daily insulin dose is 47,14 IU. The female gender had a higher incidence of sleep disturbances (47,5%), a high risk of OSAS (47,5%) and a higher percentage of restless legs (16,8%) compared to the male gender. The daily amount of insulin isrelated to BMI (p=0,025)and therisk of developing DM. Discussion/Conclusion: Given theresults obtained, we can conclude that both the daily amount of insulin and BMI have an important role in sleep quality and quality of life in type 2 diabetics.